Ross Sadler

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Journal: Journal of autoimmunity

Published: February 12, 2026

SECURE study: baseline findings from a UK prospective cohort of incidentally detected MGUS.

SECURE study: baseline findings from a UK prospective cohort of incidentally detected MGUS.

Journal: Blood cancer journal

Published: January 15, 2026

SECURE study: Incidentally detected MGUS patients have comparable depression and anxiety rates to UK general population.

SECURE study: Incidentally detected MGUS patients have comparable depression and anxiety rates to UK general population.

Journal: British journal of haematology

Published: July 26, 2025

High-throughput monoclonal gammopathy community monitoring programme.

High-throughput monoclonal gammopathy community monitoring programme.

Journal: British journal of haematology

Published: July 23, 2025

The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study.

The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study.

Journal: Rheumatology (Oxford, England)

Published: January 26, 2025

Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.

Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.

Journal: Haematologica

Published: September 17, 2023

Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services.

Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services.

Journal: British journal of haematology

Published: August 14, 2023

Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia.

Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia.

Journal: Leukemia

Published: August 10, 2023

Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.

Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.

Journal: European journal of haematology

Published: July 23, 2023

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.

Journal: Nature communications

Published: July 31, 2022

Bedside and laboratory diagnostic testing in myasthenia.

Bedside and laboratory diagnostic testing in myasthenia.

Journal: Journal of neurology

Published: December 02, 2021

Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.

Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.

Journal: British journal of haematology

Published: November 10, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026